3M’s medical solutions division has been awarded US $34.2 million from the U.S. Army Medical Research Acquisition Activity.
According to a press release, the funding will be used to develop a range of new solutions for infection prevention, as well as wound management and healing. 3M will collaborate with the University of Minnesota Medical School, the 59th Medical Wing Science & Technology Office of the Chief Scientist (59MDW/ST, lead military partner), Naval Medical Research Unit-San Antonio (NAMRU-SA), and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) in this program. 3M will lead the program, which is focused on developing treatment strategies that can be used in austere settings, especially those related to mass casualty and delayed evacuation situations.
“Successful treatment of acute, traumatic wounds requires a continuum of care that begins with easy-to-use dressings and effective infection prevention that can be applied at the point of injury, continues with portable solutions for transport, and transitions to more sophisticated solutions in hospital settings suitable for rehabilitation and reintegration of patients,” said Raymond Chiu, senior vice president of research and development for 3M’s health care business group. “3M is proud to be working with civilian and military partners to bring these solutions to fruition.”
About 3M
With global sales of US$34.2 billion, 3M is a leading producer of thousands of products ranging from chemicals, filtration systems, and safety and protection equipment to office, graphics, and healthcare equipment. For more information, visit www.3m.com.
The post 3M Receives $34M for Infection Prevention Research appeared first on ISSA.
0 Comments